Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

CytomX Therapeutics, Inc. announced encouraging interim results from its Phase 1 study of CX-2051, an EpCAM-directed antibody-drug conjugate ... Of those trades, 0 have been purchases and 5 ...

In January, we made some ... things have been progressing extremely well. We're ahead of our timeline and learning much about how to deal with sites, how to make the drug available, et cetera.

But when I was looking at those patients with the mutation, some of them didn't have hyperemesis in every ... been any progress on treatments for HG? I believe you’ve studied the diabetes drug ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst blue ...

In public, Drake continued to congratulate Lamar for a number of his successes, until 2013, when Lamar dropped a verse on Big Sean’s track “Control” that made it clear he considered himself ...

Shares of Regeneron were down nearly 8%. Sign up here. Regeneron has been looking to switch patients to a higher ... Sales of ...

Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and ...

Kennedy Jr. said the timeline to see U.S. drug prices ... "But we've been meeting with the pharmaceutical companies. They admit that this is something that should have ended a long time ago ...

Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic ... Dupixent, a drug administered by injection every two weeks, is a monoclonal antibody designed to block ...

President makes push to bring down drug prices that have long been a source of financial strain ... greedy pharmaceutical industry made over $100bn in profits last year by ripping off the American ...